Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)
HKD 1.3
(-2.99%)
HKD 1.3
(-2.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.2 Million CNY | -74.65% |
| 2022 | 12.63 Million CNY | -1.53% |
| 2021 | 12.83 Million CNY | -97.1% |
| 2020 | 442.17 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | - CNY | 0.0% |
| 2024 Q1 | - CNY | -100.0% |
| 2023 FY | 3.2 Million CNY | -74.65% |
| 2023 Q2 | 1.2 Million CNY | 0.0% |
| 2023 Q1 | 1.2 Million CNY | -36.81% |
| 2023 Q4 | 400.5 Thousand CNY | 0.0% |
| 2023 Q3 | 400.5 Thousand CNY | -66.65% |
| 2022 Q2 | 4.41 Million CNY | 0.0% |
| 2022 FY | 12.63 Million CNY | -1.53% |
| 2022 Q4 | 1.9 Million CNY | 0.0% |
| 2022 Q3 | 1.9 Million CNY | -56.97% |
| 2022 Q1 | 4.41 Million CNY | 6.76% |
| 2021 Q2 | 2.27 Million CNY | 0.0% |
| 2021 Q3 | 4.13 Million CNY | 81.61% |
| 2021 Q4 | 4.13 Million CNY | 0.0% |
| 2021 FY | 12.83 Million CNY | -97.1% |
| 2021 Q1 | 2.27 Million CNY | -98.97% |
| 2020 FY | 442.17 Million CNY | 0.0% |
| 2020 Q4 | 221.08 Million CNY | 0.0% |
| 2020 Q3 | 221.08 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 392.81 Million HKD | 99.185% |
| CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 99.662% |